The effects of aerobic training on cardiac SIRT3/FOXO3 expression and inflammatory status in obesity: An experimental study
Volume 6, Issue 4, Autumn 2026, Pages 247-257
https://doi.org/10.22122/jeoct.2026.592029.1219
Mahshid Khalili, Marina Shariati
Abstract This study investigated the effects of aerobic exercise on cardiac SIRT3 and FOXO3 expression and inflammatory cytokines in rats with obesity induced by a high-fat, high-fructose diet. Twenty-four male Wistar rats were assigned to three groups: control, high-fat/high-fructose diet (HFFD), and HFFD plus aerobic exercise (HFFD+Ex). Obesity was induced by 8 weeks of HFFD, followed by a 6-week progressive moderate-intensity aerobic treadmill training program (10-18 m/min, 10-30 min/day, 5 days/week; approximately 42-75% of individual Vmax) in the exercise group. HFFD induced obesity, dyslipidemia, and significant reductions in cardiac SIRT3 and FOXO3 expression compared with the control group (P < 0.05). The exercised group showed significantly higher SIRT3 expression compared with the HFFD group, reaching levels comparable to controls, with a very large effect size (Cohen's d = 6.10). FOXO3 expression showed a 40% increase in the exercised group compared with the HFFD group, but this difference did not reach statistical significance (P = 0.795), potentially due to limited statistical power with the sample size employed (post-hoc power = 62%). The exercised group also exhibited significantly lower circulating TNF-α and IL-1β concentrations and higher IL-10 levels compared with the HFFD group, indicating a systemic anti-inflammatory effect. However, as these cytokines were measured in blood rather than cardiac tissue, they reflect systemic inflammation and may not directly represent cardiac-specific inflammatory changes. (P < 0.05). Although FOXO3 gene expression was not significantly altered, the findings support aerobic exercise as an effective non-pharmacological strategy to mitigate obesity-related cardiac dysfunction through modulation of mitochondrial and inflammatory pathways.
